Discover the RNA people

_switch to main page

We fight for human health.

CureVac is the first company to successfully harness messenger RNA (mRNA) for medical purposes. The principle is promising; use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases.

  • CureVac Appoints Leading Experts to its Scientific Advisory Board

    Press Release of March 30, 2016 (Photo showing Ralf Clemens, source: Fiocruz)

    Read more
  • CureVac strengthens supervisory board to support global growth opportunities and mRNA product expansion

    Press Release of March 18, 2016

    Read more
  • CureVac announces “MERAN” has been approved by the WHO as suffix for mRNA drug substances

    Press Release of Feb 18, 2016

    Read more
  • Media Report in LaBiotech on Jan 5, 2016

    "Ultimate Review: How Could mRNA Overtake all other Biologicals in Medicine?"

    Read more
  • CureVac raises $110 Million in a private placement

    Further investment for development of mRNA products

    Read more
  • Work@CureVac

    Do you want to fight together with us for human health? You will find current vacancies on our CareerPortal.

    Read more